CORDIS
EU research results

CORDIS

English EN

Translational studies of HEAD and neck cancer in South America and Europe

Project information

Grant agreement ID: 825771

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 996 233,75

  • EU contribution

    € 3 153 447,50

Coordinated by:

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

France

Objective

Worldwide, more than 550,000 new cases of head and neck cancer (HNC) occur each year, resulting in approximately 300,000 deaths annually. It is the 6th most common cancer in both Europe and South America. A major reason for the high mortality rate for this cancer is the late stage of diagnosis for many patients. Accurate assessment of the prognosis of HNC cases also allows for appropriate treatment decisions. HEADSpAcE will bring together a consortium of 15 partners with a long and successful record of collaboration in HNC. The impact of HEADSpAcE will be to understand reasons for late diagnosis and reduce the proportion of HNC that are diagnosed at a very late stage. It will identify the most appropriate fashion for diagnosis cancer caused by human papilloma virus, and also provide genomic evidence of strong predictors of prognosis that will have the potential to improve care and reduce treatment related morbidity. We will also develop guidelines for implementation into clinical care.

Coordinator

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

Address

150 Cours Albert Thomas
69372 Lyon Cedex 08

France

Activity type

Other

EU Contribution

€ 720 000

Participants (14)

INSTITUT CATALA D'ONCOLOGIA

Spain

EU Contribution

€ 249 985

UNIVERSITA DEGLI STUDI DI TORINO

Italy

EU Contribution

€ 257 203,75

UNIVERZITA KARLOVA

Czechia

EU Contribution

€ 140 000

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Germany

EU Contribution

€ 139 118,75

UNIVERSITY OF GLASGOW

United Kingdom

EU Contribution

€ 300 000

UNIVERSITY OF BRISTOL

United Kingdom

EU Contribution

€ 220 018,75

FUNDACAO ANTONIO PRUDENTE

Brazil

FUNDACAO PIO XII

Brazil

ASSOCIACAO FEMININA DE EDUCACAO E COMBATE AO CANCER

Brazil

Universidad El Bosque

Colombia

EU Contribution

€ 240 000

UNIVERSIDAD DE LA REPUBLICA

Uruguay

EU Contribution

€ 120 000

UNIVERSIDAD DE BUENOS AIRES

Argentina

EU Contribution

€ 120 000

THE UNIVERSITY OF TENNESSEE

United States

EU Contribution

€ 647 121,25

MINISTERIO DA SAUDE

Brazil

Project information

Grant agreement ID: 825771

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 996 233,75

  • EU contribution

    € 3 153 447,50

Coordinated by:

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

France